San Francisco, United States
Allelica, Inc, founded in 2017, is on a mission to revolutionize clinical genomics, rooted in a data-driven approach to primary prevention. With their slogan, "Empowering the next generation of clinical genomics: Monogenic + Polygenic," Allelica is carving a niche in the biotech landscape.
The company offers a unique Software as a Service and on-premise infrastructure, enabling clinical genetics labs and biopharma companies to conduct Polygenic Risk Score (PRS) analysis across multiple ancestries. This innovative capability democratizes access to high-quality genomic insights, previously showcased in leading journals such as the American Heart Association Journal and at high-profile conferences like ASHG and ESC.
Headquartered in the United States, Allelica's potential was recognized in a $1.75M Seed Round investment by Valor Ventures and Pi Campus on 05 March 2021. Investors looking at the intersection of genomics and personalized medicine may find Allelica's offerings particularly compelling in the evolving landscape of healthcare innovation.
